Cite

HARVARD Citation

    Ighani, A. et al. (2018). Efficacy and Safety of Apremilast Monotherapy for Moderate to Severe Psoriasis: Retrospective Study. Journal of cutaneous medicine and surgery. 22 (3), pp. 290-296. [Online]. 
  
Back to record